Charisse R. Lillie - 31 Dec 2023 Form 4 Insider Report for EXELON CORP (EXC)

Role
Director
Signature
Elizabeth M Hensen, attorney-in-fact for Charisse R Lille
Issuer symbol
EXC
Transactions as of
31 Dec 2023
Net transactions value
+$41,249
Form type
4
Filing time
02 Jan 2024, 20:48:50 UTC
Previous filing
02 Oct 2023
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common stock- deferred stock units Award $41,249 +1,052 +59% $39.21 2,849 31 Dec 2023 By Exelon Corp. Directors Deferred Stock Unit Plan F1
holding EXC Common stock 7,246 31 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXC Deferred phantom share equivalents 3,556 31 Dec 2023 Common stock 3,556 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 16 additional shares acquired through automatic dividend reinvestment.
F2 Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3 Balance includes 31 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.